Management of anxious disorders in neurological diseases;Prise en charge des troubles anxieux dans le cadre d'atteintes neurologiques

Schweizer Archiv fur Neurologie und Psychiatrie

Volumn 155, Issue 8, 2004, Pages 407-413

  Bruggimann, Laure ^a   Annoni, J M ^a,b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b HUG   (Switzerland)

Author keywords

Anxiety; Dementia; Multiple sclerosis; Rehabilitation; Stroke; Therapy

Indexed keywords

AGING; ANXIETY DISORDER; ARTICLE; BEHAVIOR DISORDER; BEHAVIOR THERAPY; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; COGNITIVE THERAPY; DEMENTIA; HUMAN; MOOD DISORDER; MORBIDITY; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEUROPSYCHIATRY; PATIENT EDUCATION; PSYCHOTHERAPY; SELF CONCEPT; SELF CONTROL; STROKE;

EID: 13544253603     PISSN: 02587661     EISSN: None     Source Type: Journal    
DOI: 10.4414/sanp.2004.01536     Document Type: Article

References (47)

1. Jopson NM, Moss-Morris R. The role of illness severity and illness representations in adjusting to multiple sclerosis. J Psychosom Res 2003;54:503-11.
2. Croquelois A, Assal G, Annoni JM, Staub F, Gronchi A, Bruggimann L, et al. Diseases of the nervous system: patient's etiological beliefs. JNNP (in press).
3. Bruchon-Schweitzer M. Psychologie de la santé. Modèles, concepts et méthodes. Paris: Dunod; 2002.
4. Maeland JG, Havik OE. Psychological predictors for return to work after a myocardial infarction. J Psychosom Res 1987;31:471-81.
5. Tesar N, Baumhackl U, Kopp M, Günther V. Effects of psychological group therapy in patients with multiple sclerosis. Acta Neurol Scand 2003;107:394-9.
6. Starkstein SE, Cohen BS, Fedoroff P, Parikh RM, Price TR, Robinson RG. Relationship between anxiety disorders and depression disorders in patients with cerebrovascular injury. Arch Gen Psychiatry 1990;47:246-51.
7. Astrom M. Generalized anxiety disorder in stroke patients. A 3-year longitudinal study. Stroke 1996;27:270-5.
8. Burvill PW, Johnson GA, Jamrozik KD, Anderson CS, Stewart-Wynne EG, Chakera TME. Anxiety disorders after stroke: results from the Perth Community Stroke Study. Br J Psychiatry 1995;166:328-32.
9. Berry E. Post-traumatic stress disorder after subarachnoid haemorrhage. Br J Clin Psychol 1998;37:365-7.
10. Sampson MJ, Kinderman P, Watts S, Sembi S. Psychopathology and autobiographical memory in stroke and non-stroke hospitalised patients. Int J Geriatr Psychiatry 2003;18:23-32.
11. Castillo CS, Starkstein SE, Fedoroff JP, Price TR, Robinson RG. Generalized anxiety disorders after stroke. J Nerv Ment Dis 1993;181:100-6.
12. Schultz SK, Castillo CS, Kosier JT, Robison RG. Generalized anxiety and depression. Am J Geriatr Psychiatry 1997;5:229-37.
13. Castillo CS, Schultz SK, Robinson RG. Clinical correlates of early-onset and late-onset poststroke generalized anxiety. Am J Psychiatry 1995;152:1174-9.
14. Kneebone II, Dumore E. Psychological management of post-stroke depression. Br J Clin Psychol 2000;39:53-65.
15. Lincoln NB, Flannaghan T, Rother L. Evaluation of cognitive behavioural treatment for depression after stroke: a pilot study. Clin Rehabil 1997;11:114-22.
16. Lincoln NB, Flannaghan T. Cognitive behavioural psychotherapy for depression following stroke. A randomised controlled trial. Stroke 2003;34:111-5.
17. Petrie KJ, Cameron LD, Ellis CJ, Buick D, Weinman J. Changing illness perceptions after myocardial infarction: an early intervention randomised controlled trial. Psychosom Med 2002;64:580-6.
18. Weinstein ND. Optimistic biases about personal risks. Science 1989;246:1232-3.
19. Miche E, Herrmann G, Wirtz U, Laki H, Barth M, Radzewitz A. Effects of education, self-care instruction and physical exercise on patients with chronic heart failure. Z Kardiol 2003;92:985-93.
20. Moran M, Walsh C, Lynch A, Coen RF, Coakley D, Lawlor BA. Syndromes of behavioural and psychological symptoms in mild Alzheimer's disease. Int J Geriatr Psychiatry 2004;19:359-64.
21. Hirono N, Cummings JL. Neuropsychiatric aspects of dementia with Lewy bodies. Curr Psychiatry Rep 1999;1:85-92.
22. Harwood DG, Sultzer DL, Wheatley MV. Impaired insight in Alzheimer's disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances. Neuropsychiatry Neuropsychol Behav Neurol 2000;13: 83-8.
23. Lebert F, Robert P, Rigaud SA. Management of behavioral disorders in dementia patients. Rev Neurol 2000;156:767-72.
24. Ballard C, Boyle A, Bowler C, Lindesay J. Anxiety disorders in dementia sufferers. Int J Geriatr Psychiatry 1996;11:987-90.
25. Burney-Puckett M. Sundown syndrome: etiology and management. J Psychosoc Nurs Ment Health Serv 1996;34:40-3.
26. Bramesfeld A, Adler G, Brassen S, Schnitzler M. Day-clinic treatment of late-life depression. Int J Geriatr Psychiatry 2001;16:82-7.
27. Canuto A. Hôpital de jour psychogériatrique: une expérience de communauté thérapeutique. Méd Hyg 2004;62:1429-32.
28. Tzaut Sciarini P. L'art-thérapie en psychiatrie de l'âgé. Méd Hyg 2004;62:1438-42.
29. Woods P, Ashley J. Simulated presence therapy: using selected memories to manage problem behaviors in Alzheimer's disease patients. Geriatr Nurs 1995;16:9-14.
30. Camberg L, Woods P, Ooi WL, Hurley A, Volicer L, Ashley J, et al. Evaluation of Simulated Presence: a personalized approach to enhance well-being in persons with Alzheimer's disease. J Am Geriatr Soc 1999;47:446-52.
31. Mohr DC, Cox D. Multiple sclerosis: empirical literature for the clinical health psychologist. J Clin Psychol 2001;57:479-99.
32. Leger E, Freeston MH, Ladouceur R, Noreau L, Tremblay L. Manifestations anxieuses chez des personnes ayant la sclérose en plaques ou une autre déficience physique. J Réadapt Méd 1998;18:4-8.
33. Léger E, Ladouceur R, Freeston MH. Anxiety and physical limitation: a complex relation. Encephale 2002;28:205-9.
34. Janssens AC, van Doorn PA, de Boer JB, van der Meche FG, Passchier J, Hintzen RQ. Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners. Acta Neurol Scand 2003;108:389-95.
35. Janssens AC, van Doom PA, de Boer JB, van der Meche FG, Passchier J, Hintzen RQ. Perception of prognostic risk in patients with multiple sclerosis: the relationship with anxiety, depression, and disease-related distress. J Clin Epidemiol 2004;57:180-6.
36. Zorzon M, de Masi R, Nasuelli D, Ukmar M, Mucelli RP, Cazzato G, et al. Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. J Neurol 2001;248:416-21.
37. Feinstein A, Roy P, Lobaugh N, Feinstein K, O'Connor P, Black S. Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 2004;62:586-90.
38. Larcombe NA, Wilson PH. An evaluation of cognitive-behaviour therapy for depression in patients with multiple sclerosis. Br J Psychiatry 1984;145:366-71.
39. Foley FW, Bedell JR, LaRocca NG, Scheinberg LC, Reznikoff M. Efficacy of stress-inoculation training in coping with multiple sclerosis. J Consult Clin Psychol 1987;55:919-22.
40. Crawford JD, McIvor GP. Stress management for multiple sclerosis patients. Psychol Rep 1987;61:423-9.
41. Mohr DC, Likosky W, Bertagnolli A, Goodkin DE, Van Der Wende J, Dwyer P, et al. Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. J Consult Clin Psychol 2000;68:356-61.
42. Crawford JD, McIvor GP. Group psychotherapy: benefits in multiple sclerosis. Arch Phys Med Rehabil 1985;66:810-3.
43. Mohr DC, Boudewyn AC, Goodkin DE, Bostrom A, Epstein L. Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol 2001;69:942-9.
44. Riazi A, Thompson AJ, Hobart JC. Self-efficacy predicts self-reported health status in multiple sclerosis. Mult Scler 2004;10:61-6.
45. Spalletta G, Caltagirone C. Sertraline treatment of post-stroke major depression: an open study in patients with moderate to severe symptoms. Funct Neurol 2003;18:227-32.
46. Finkel SI, Mintzer JE, Dysken M, Krishnan KR, Burt T, McRae T. A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil. Int J Geriatr Psychiatry 2004;19:9-18.
47. Mohr DC, Classen C, Barrera M. The relationship between social support, depression and treatment for depression in people with multiple sclerosis. Psychol Med 2004;34:533-41.